stoxline Quote Chart Rank Option Currency Glossary
  
IM Cannabis Corp. (IMCC)
0.1842  -0.033 (-15.12%)    06-18 10:46
Open: 0.1868
High: 0.1941
Volume: 24,312,013
  
Pre. Close: 0.217
Low: 0.181
Market Cap: 1(M)
Technical analysis
2026-06-18 10:16:04 AM
Short term     
Mid term     
Targets 6-month :  0.39 1-year :  0.5
Resists First :  0.33 Second :  0.43
Pivot price 0.26
Supports First :  0.18 Second :  0.15
MAs MA(5) :  0.23 MA(20) :  0.26
MA(100) :  0.55 MA(250) :  1.43
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  9.4 D(3) :  14.5
RSI RSI(14): 34.5
52-week High :  3.75 Low :  0.18
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ IMCC ] has closed below the lower bollinger band by 6.2%. Bollinger Bands are 52.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 44 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.23 - 0.23 0.23 - 0.23
Low: 0.2 - 0.2 0.2 - 0.2
Close: 0.21 - 0.22 0.22 - 0.22
Company Description

IM Cannabis Corp. specializes in the cultivation, production, and provision of medicinal cannabis goods throughout international markets such as Israel, Germany, and Canada. The company offers a range of cannabis products, including flowers and specifically formulated cannabis extracts, marketed under its IMC brand. Furthermore, it supplies dried flower, pre-rolled products, and compressed hashish via its WAGNERS and Highland Grow labels. IM Cannabis Corp. serves a broad customer base, addressing the needs of both medical patients and adult recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.

Headline News

Thu, 18 Jun 2026
IM Cannabis to sell European assets for C$10.5M debt relief - grafa.com

Thu, 18 Jun 2026
IMCC Negotiates Sale of European Assets to Slil.com Holding Ltd. - GuruFocus

Thu, 18 Jun 2026
IM Cannabis Corp. (Nasdaq: IMCC) moves to sell European assets, shift focus to Israel - Stock Titan

Thu, 18 Jun 2026
IM Cannabis weighs European sale to slash debt by C$10.5M - Stock Titan

Wed, 17 Jun 2026
IM Cannabis Corp (IMCC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Wed, 17 Jun 2026
IM Cannabis Corp (IMCC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Shares Out 9 (M)
Shares Float 4 (M)
Held by Insiders 35.1 (%)
Held by Institutions 0.4 (%)
Shares Short 103 (K)
Shares Short P.Month 44 (K)
Stock Financials
EPS -2.25
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -0.62
Profit Margin -27.3 %
Operating Margin -19.4 %
Return on Assets (ttm) -14.7 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth -30.7 %
Gross Profit (p.s.) 0.84
Sales Per Share 5.64
EBITDA (p.s.) -0.71
Qtrly Earnings Growth 0 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -4 (M)
Stock Valuations
PE Ratio -0.09
PEG Ratio 0
Price to Book value -0.31
Price to Sales 0.03
Price to Cash Flow 24.77
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android